{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:20:55Z","timestamp":1790176855410,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","sempedneurjnl.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Pediatric Neurology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.spen.2017.06.001","type":"journal-article","created":{"date-parts":[[2017,6,30]],"date-time":"2017-06-30T14:16:55Z","timestamp":1498832215000},"page":"129-134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Dominant Optic Atrophy and Leber\u2019s Hereditary Optic Neuropathy: Update on Clinical Features and Current Therapeutic Approaches"],"prefix":"10.1016","volume":"24","author":[{"given":"Bo Young","family":"Chun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Joseph F.","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.spen.2017.06.001_bib1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.preteyeres.2010.11.002","article-title":"Mitochondrial optic neuropathies\u2014Disease mechanisms and therapeutic strategies","volume":"30","author":"Yu-Wai-Man","year":"2011","journal-title":"Prog Retinal Eye Res"},{"key":"10.1016\/j.spen.2017.06.001_bib2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/eye.2014.37","article-title":"Treatment strategies for inherited optic neuropathies: Past, present and future","volume":"28","author":"Yu-Wai-Man","year":"2014","journal-title":"Eye"},{"key":"10.1016\/j.spen.2017.06.001_bib3","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/ICU.0000000000000314","article-title":"Dominant optic atrophy: Updates on the pathophysiology and clinical manifestations of the optic atrophy 1 mutation","volume":"27","author":"Chun","year":"2016","journal-title":"Curr Opin Ophthalmol"},{"issue":"4","key":"10.1016\/j.spen.2017.06.001_bib4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.survophthal.2009.10.002","article-title":"The neuro-ophthalmology of mitochondrial disease","volume":"55","author":"Fraser","year":"2010","journal-title":"Survey Ophthalmol"},{"issue":"1","key":"10.1016\/j.spen.2017.06.001_bib5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.preteyeres.2003.10.003","article-title":"Mitochondrial dysfunction as a cause of optic neuropathies","volume":"23","author":"Carelli","year":"2004","journal-title":"Prog Retinal Eye Res"},{"key":"10.1016\/j.spen.2017.06.001_bib6","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/WCO.0b013e32835c5f0b","article-title":"Mitochondrial dysfunction in optic neuropathies: Animal models and therapeutic options","volume":"26","author":"Carelli","year":"2013","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.spen.2017.06.001_bib7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1750-1172-7-46","article-title":"Dominant optic atrophy","volume":"7","author":"Lenaers","year":"2012","journal-title":"Orphanet J Rare Dis"},{"issue":"12","key":"10.1016\/j.spen.2017.06.001_bib8","first-page":"2448","article-title":"Dominant optic atrophy: Novel OPA1 mutations and revised prevalence estimates","volume":"120","author":"Yu-Wai-Man","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.spen.2017.06.001_bib9","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ajo.2006.12.038","article-title":"Autosomal dominant optic atrophy: Penetrance and expressivity in patients with OPA1 mutations","volume":"143","author":"Cohn","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.spen.2017.06.001_bib10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1471-2350-13-65","article-title":"Dominant optic atrophy in Denmark\u2014Report of 15 novel mutations in OPA1, using a strategy with a detection rate of 90%","volume":"13","author":"Almind","year":"2012","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.spen.2017.06.001_bib11","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s00439-001-0633-y","article-title":"Mutation spectrum and splicing variants in the OPA1 gene","volume":"109","author":"Delettre","year":"2001","journal-title":"Hum Genet"},{"key":"10.1016\/j.spen.2017.06.001_bib12","doi-asserted-by":"crossref","first-page":"15927","DOI":"10.1073\/pnas.0407043101","article-title":"OPA1 requires mitofusin 1 to promote mitochondrial fusion","volume":"101","author":"Cipolat","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.spen.2017.06.001_bib13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1750-1326-8-32","article-title":"Dominant optic atrophy, OPA1, and mitochondrial quality control: Understanding mitochondrial network dynamics","volume":"8","author":"Alavi","year":"2013","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.spen.2017.06.001_bib14","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/ana.20278","article-title":"Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy","volume":"56","author":"Lodi","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.spen.2017.06.001_bib15","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/brain\/awm335","article-title":"OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion","volume":"131","author":"Zanna","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.spen.2017.06.001_bib16","doi-asserted-by":"crossref","first-page":"7743","DOI":"10.1074\/jbc.C200677200","article-title":"Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis","volume":"278","author":"Olichon","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.spen.2017.06.001_bib17","doi-asserted-by":"crossref","first-page":"E692","DOI":"10.1002\/humu.21025","article-title":"Molecular screening of 980 cases of suspected hereditary optic neuropathy with a report on 77 Novel OPA1Mutations","volume":"30","author":"Ferre","year":"2009","journal-title":"Human Mutation"},{"key":"10.1016\/j.spen.2017.06.001_bib18","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1055\/s-0035-1563574","article-title":"Therapeutic approaches to inherited optic neuropathies","volume":"35","author":"Yu-Wai-Man","year":"2015","journal-title":"Semin Neurol"},{"key":"10.1016\/j.spen.2017.06.001_bib19","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.biocel.2009.04.012","article-title":"OPA1-associated disorders: Phenotypes and pathophysiology","volume":"41","author":"Amati-Bonneau","year":"2009","journal-title":"Int J Biochem Cell Biol"},{"issue":"suppl 54","key":"10.1016\/j.spen.2017.06.001_bib20","first-page":"S1","article-title":"Infantile optic atrophy with dominant mode of inheritance: A clinical and genetic study of 19 Danish families","volume":"164","author":"Kjer","year":"1959","journal-title":"Acta Ophthalmol Suppl"},{"key":"10.1016\/j.spen.2017.06.001_bib21","first-page":"p. 465","article-title":"Hereditary optic neuropathies","volume":"vol 1","author":"Newman","year":"2005"},{"issue":"8","key":"10.1016\/j.spen.2017.06.001_bib22","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.ophtha.2009.12.038","article-title":"The prevalence and natural history of dominant optic atrophy due to OPA1 mutations","volume":"117","author":"Yu-Wai-Man","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.spen.2017.06.001_bib23","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.ajo.2014.05.034","article-title":"Early macular retinal ganglion cell loss in dominant optic atrophy: Genotype-phenotype correlation","volume":"158","author":"Barboni","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.spen.2017.06.001_bib24","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3109\/08820538.2013.825296","article-title":"Autosomal dominant hereditary optic neuropathy (ADOA): A review of the genetics and clinical manifestations of ADOA and ADOA+","volume":"28","author":"Skidd","year":"2013","journal-title":"Semin Ophthalmol"},{"issue":"7","key":"10.1016\/j.spen.2017.06.001_bib25","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1167\/iovs.09-4659","article-title":"Mitochondrial DNA defects and selective extraocular muscle involvement in CPEO","volume":"51","author":"Greaves","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.spen.2017.06.001_bib26","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1755-3768.1983.tb01424.x","article-title":"Histopathology of eye, optic nerve and brain in a case of dominant optic atrophy","volume":"61","author":"Kjer","year":"1983","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"10.1016\/j.spen.2017.06.001_bib27","doi-asserted-by":"crossref","first-page":"7629","DOI":"10.1167\/iovs.15-17951","article-title":"Electrophysiological ON and OFF responses in autosomal dominant optic atrophy","volume":"56","author":"Morny","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.spen.2017.06.001_bib28","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1093\/brain\/awq155","article-title":"Melanopsin retinal ganglion cells are resistant to neurodegeneration in mitochondrial optic neuropathies","volume":"133","author":"La Morgia","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.spen.2017.06.001_bib29","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fneur.2015.00005","article-title":"Dissociation of pupillary post-illumination responses from visual function in confirmed OPA1 c.983A>G and c.2708_2711delTTAG autosomal dominant optic atrophy","volume":"6","author":"Nissen","year":"2015","journal-title":"Front Neurol"},{"issue":"2","key":"10.1016\/j.spen.2017.06.001_bib30","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1136\/bjo.83.2.231","article-title":"Histochemical localization of mitochondrial enzyme activity in human optic nerve and retina","volume":"83","author":"Andrews","year":"1999","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.spen.2017.06.001_bib31","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cell.2006.06.021","article-title":"Mitochondrial rhomboid PARL regulates cytochrome c release during apoptosis viaOPA1-dependent cristae remodeling","volume":"126","author":"Cipolat","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.spen.2017.06.001_bib32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jns.2015.02.047","article-title":"Analysis of opa1 isoforms expression and apoptosis regulation in autosomal dominant optic atrophy patients with mutations in the opa1 gene","volume":"351","author":"Formichi","year":"2015","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.spen.2017.06.001_bib33","first-page":"37","article-title":"Functions and dysfunctions of the human dynamin OPA1","volume":"1657","author":"Lenaers","year":"2004","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"10.1016\/j.spen.2017.06.001_bib34","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/ana.21385","article-title":"Hereditary optic neuropathies share a common mitochondrial coupling defect","volume":"63","author":"Chevrollier","year":"2008","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.spen.2017.06.001_bib35","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1086\/346066","article-title":"The epidemiology of Leber hereditary optic neuropathy in the North East of England","volume":"72","author":"Man","year":"2003","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1016\/j.spen.2017.06.001_bib36","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/ana.410420407","article-title":"In vivo skeletal muscle mitochondrial function in Leber\u2019s hereditary optic neuropathy assessed by 31P magnetic resonance spectrometry","volume":"42","author":"Lodi","year":"1997","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.spen.2017.06.001_bib37","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1074\/jbc.M807321200","article-title":"Respiratory complex 1 dysfunction due to mitochondrial DNA mutations shifts the voltage threshold for opening of the permeability transition pore toward resting levels","volume":"284","author":"Porcelli","year":"2009","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.spen.2017.06.001_bib38","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/jmg.2007.054270","article-title":"Inherited mitochondrial optic neuropathies","volume":"46","author":"Yu-Wai-Man","year":"2009","journal-title":"J Med Genet"},{"issue":"7","key":"10.1016\/j.spen.2017.06.001_bib39","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1167\/iovs.08-3166","article-title":"Quality of life in patients with leber hereditary optic neuropathy","volume":"50","author":"Kirkman","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.spen.2017.06.001_bib40","first-page":"77","article-title":"Pedigree analysis in leber hereditary optic neuropathy families with a pathogenic mtDNA mutation","volume":"57","author":"Harding","year":"1995","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1016\/j.spen.2017.06.001_bib41","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/archopht.1993.01090040087038","article-title":"Lebers hereditary optic neuropathy\u2013Clinical manifestations of the 14484 mutation","volume":"111","author":"Johns","year":"1993","journal-title":"Arch Ophthalmol"},{"issue":"12","key":"10.1016\/j.spen.2017.06.001_bib42","doi-asserted-by":"crossref","first-page":"5303","DOI":"10.1167\/iovs.06-0520","article-title":"Leber\u2032s hereditary optic neuropathy with childhood onset","volume":"47","author":"Barboni","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.spen.2017.06.001_bib43","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1167\/iovs.08-2695","article-title":"Association of optic disc size with development and prognosis of Leber\u2019s hereditary optic neuropathy","volume":"50","author":"Ramos","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.spen.2017.06.001_bib44","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0161-6420(96)30665-9","article-title":"Ophthalmologic findings in Leber hereditary optic neuropathy, with special reference to mtDNA mutations","volume":"103","author":"Nikoskelainen","year":"1996","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.spen.2017.06.001_bib45","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ophtha.2004.09.033","article-title":"Retinal nerve fiber layer evaluation by optical coherence tomography in unaffected carriers with Leber\u2019s hereditary optic neuropathy mutations","volume":"112","author":"Savini","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.spen.2017.06.001_bib46","first-page":"51","article-title":"Subclinical carriers and conversions in Leber hereditary optic neuropathy: A prospective psychophysical study","volume":"104","author":"Sadun","year":"2006","journal-title":"Transact Am Ophthalmol Soc"},{"key":"10.1016\/j.spen.2017.06.001_bib47","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/WNO.0000000000000250","article-title":"Superoxide generation explains common features of optic neuropathies associated with cecocentral scotomas","volume":"35","author":"Levin","year":"2015","journal-title":"J Neuro-Ophthalmol"},{"key":"10.1016\/j.spen.2017.06.001_bib48","first-page":"223","article-title":"Leber\u2019s hereditary optic neuropathy differentially affects smaller axons in the optic nerve","volume":"98","author":"Sadun","year":"2000","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"12","key":"10.1016\/j.spen.2017.06.001_bib49","doi-asserted-by":"crossref","first-page":"7608","DOI":"10.1167\/iovs.12-10452","article-title":"Mathematically modeling the involvement of axons in Leber\u2019s hereditary optic neuropathy","volume":"53","author":"Pan","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"49","key":"10.1016\/j.spen.2017.06.001_bib50","doi-asserted-by":"crossref","first-page":"20065","DOI":"10.1073\/pnas.1217113109","article-title":"Mouse mtDNA mutant model of Leber hereditary optic neuropathy","volume":"109","author":"Lin","year":"2012","journal-title":"PNAS"},{"issue":"1-2","key":"10.1016\/j.spen.2017.06.001_bib51","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.bbabio.2004.05.009","article-title":"Bioenergetics shapes cellular death pathways in Leber\u2019s hereditary optic neuropathy: A model of mitochondrial neurodegeneration","volume":"1658","author":"Carelli","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.spen.2017.06.001_bib52","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/ICU.0000000000000212","article-title":"Is there treatment for Leber hereditary optic neuropathy?","volume":"26","author":"Peragallo","year":"2015","journal-title":"Curr Opin Ophthalmol"},{"issue":"3","key":"10.1016\/j.spen.2017.06.001_bib53","doi-asserted-by":"crossref","first-page":"e17963","DOI":"10.1371\/journal.pone.0017963","article-title":"NQO1-dependent redox cycling of idebenone: effects on cellular redox potential and energy levels","volume":"6","author":"Haefeli","year":"2011","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1016\/j.spen.2017.06.001_bib54","doi-asserted-by":"crossref","first-page":"e45182","DOI":"10.1371\/journal.pone.0045182","article-title":"Idebenone protects against retinal damage and loss of vision in a mouse model of Leber\u2019s hereditary optic neuropathy","volume":"7","author":"Heitz","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.spen.2017.06.001_bib55","first-page":"CD004426","article-title":"Treatment for mitochondrial disorders","volume":"4","author":"Pfeffer","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.spen.2017.06.001_bib56","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.bbrc.2005.11.035","article-title":"Inhibition of glycerophosphate-dependent H2O2 generation in brown fat mitochondria by idebenone","volume":"339","author":"Rauchova","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.spen.2017.06.001_bib57","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1093\/brain\/awr170","article-title":"A randomized placebo-controlled trial of idebenone in Leber\u2019s hereditary optic neuropathy","volume":"134","author":"Klopstock","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.spen.2017.06.001_bib58","doi-asserted-by":"crossref","first-page":"e230","DOI":"10.1093\/brain\/aws279","article-title":"Persistence of the treatment effect of idebenone in Leber\u2019s hereditary optic neuropathy","volume":"136","author":"Klopstock","year":"2013","journal-title":"Brain"},{"issue":"pt 9","key":"10.1016\/j.spen.2017.06.001_bib59","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.1093\/brain\/awr180","article-title":"Idebenone treatment in Leber\u2019s hereditary optic neuropathy","volume":"134","author":"Carelli","year":"2011","journal-title":"Brain"},{"issue":"pt 2","key":"10.1016\/j.spen.2017.06.001_bib60","doi-asserted-by":"crossref","first-page":"e231","DOI":"10.1093\/brain\/aws280","article-title":"Idebenone treatment in patients with OPA1-mutant dominant optic atrophy","volume":"136","author":"Barboni","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.spen.2017.06.001_bib61","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1016\/j.bmcl.2011.04.085","article-title":"\u03b1-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging","volume":"21","author":"Shrader","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.spen.2017.06.001_bib62","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ymgme.2011.10.009","article-title":"Initial experience in the treatment of inherited mitochondrial disease with EPI-743","volume":"105","author":"Enns","year":"2012","journal-title":"Mol Genet Metab"},{"issue":"3","key":"10.1016\/j.spen.2017.06.001_bib63","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/archneurol.2011.2972","article-title":"Effect of EPI-743 on the clinical course of the mitochondrial disease Leber hereditary optic neuropathy","volume":"69","author":"Sadun","year":"2012","journal-title":"Arch Neurol"},{"issue":"pt 2","key":"10.1016\/j.spen.2017.06.001_bib64","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/brain\/awt343","article-title":"Efficient mitochondrial biogenesis drives incomplete penetrance in Leber\u2019s hereditary optic neuropathy","volume":"137","author":"Giordano","year":"2014","journal-title":"Brain"},{"issue":"pt 2","key":"10.1016\/j.spen.2017.06.001_bib65","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/brain\/awu005","article-title":"Weighing in on Leber hereditary optic neuropathy: Effects of mitochondrial mass","volume":"137","author":"Hirano","year":"2014","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.spen.2017.06.001_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1167\/iovs.06-0789","article-title":"The mutant human ND4 subunit of complex I induces optic neuropathy in the mouse","volume":"48","author":"Qi","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.spen.2017.06.001_bib67","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/ana.10354","article-title":"Rescue of a mitochondrial deficiency causing Leber hereditary optic neuropathy","volume":"52","author":"Guy","year":"2002","journal-title":"Ann Neurol"},{"issue":"9","key":"10.1016\/j.spen.2017.06.001_bib68","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1167\/iovs.08-3214","article-title":"Efficiency and safety of AAV mediated gene delivery of the human ND4 complex I subunit in the mouse visual system","volume":"50","author":"Guy","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.spen.2017.06.001_bib69","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.crvi.2013.11.011","article-title":"Gene therapy for mitochondrial diseases: Leber hereditary optic neuropathy as the first candidate for a clinical trial","volume":"337","author":"Cwerman-Thibault","year":"2014","journal-title":"C R Biol"},{"issue":"4","key":"10.1016\/j.spen.2017.06.001_bib70","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1001\/jamaophthalmol.2013.7971","article-title":"Trial end points and natural history in patients with G11778A Leber hereditary optic neuropathy: Preparation for gene therapy clinical trial","volume":"132","author":"Lam","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"10.1016\/j.spen.2017.06.001_bib71","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ophtha.2015.10.025","article-title":"Gene therapy for Leber hereditary optic neuropathy: Initial results","volume":"123","author":"Feuer","year":"2016","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.spen.2017.06.001_bib72","doi-asserted-by":"crossref","first-page":"21587","DOI":"10.1038\/srep21587","article-title":"Efficacy and safety of rAAV2-ND4 treatment for Leber\u2019s hereditary optic neuropathy","volume":"19","author":"Wan","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.spen.2017.06.001_bib73","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ebiom.2016.07.002","article-title":"Long-term outcomes of gene therapy for the treatment of Leber\u2019s hereditary optic neuropathy","volume":"10","author":"Yang","year":"2016","journal-title":"EBioMedicine"}],"container-title":["Seminars in Pediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909117300852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909117300852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T15:23:24Z","timestamp":1535642604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071909117300852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":73,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S1071909117300852"],"URL":"https:\/\/doi.org\/10.1016\/j.spen.2017.06.001","relation":{},"ISSN":["1071-9091"],"issn-type":[{"value":"1071-9091","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dominant Optic Atrophy and Leber\u2019s Hereditary Optic Neuropathy: Update on Clinical Features and Current Therapeutic Approaches","name":"articletitle","label":"Article Title"},{"value":"Seminars in Pediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.spen.2017.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}